Q3 Results 2025 Highlights: Gland Pharma's revenue drop by 10% to Rs 1,384 crore

Stocks of companies announcing their Q3 results are closely monitored as markets show a downward trend following Finance Minister Nirmala Sitharaman's announcement of the 2025-2026 Budget on February 1.

Gland Pharma's Financial Performance:

Revenue: Rs 1,384 crore (down 10% YoY)

Net Profit: Rs 205 crore (up 7% YoY)

Total Income: Rs 1,443 crore

Total Expenses: Rs 1,143 crore

Other Key Earnings Announcements:

Garden Reach Shipbuilders & Engineers declared an interim dividend of Rs 8.95 per share and reported a net profit increase of 11%, reaching Rs 98 crore, with a 38% YoY rise in revenue to Rs 1,271 crore.

HFCL experienced a 12% decline in net profit to Rs 73 crore, with a slight drop of 2% in revenue to Rs 1,012 crore.

Premier Energies saw an impressive 491% increase in net profit, surging to Rs 255 crore, while its revenue skyrocketed by 140% to Rs 1,713 crore.

Sky Gold recorded a 309% jump in net profit to Rs 36.5 crore, with its revenue more than doubling to Rs 998 crore.

Divi's Labs saw a remarkable 65% increase in net profit to Rs 589 crore, with revenue rising by 25% to Rs 1,855 crore. Meanwhile, KPR Mill posted an 8% rise in net profit to Rs 202 crore.

Market Movements:

Sky Gold's shares surged by 5% after reporting robust Q3 results.

Divi's Labs shares gained nearly 4%, reflecting the strong financial performance.

Several other companies, including Tata Chemicals, Power Grid, and Premier Energies, are set to announce their Q3 results, with Power Grid expected to report muted profit growth.